| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 05/21/2004 | WO2004041163A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004028452A3 Method for preparing crambescidin core acid intermediates and their use for preparing crambescidin alkaloid analogs as therapeutic agents |
| 05/21/2004 | CA2503713A1 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2503118A1 Process for electrochemical oxidation of ferrocyanide to ferricyanide |
| 05/21/2004 | CA2502477A1 Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents |
| 05/21/2004 | CA2502429A1 Antiinflammation agents |
| 05/21/2004 | CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/20/2004 | US20040097560 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
| 05/20/2004 | US20040097558 Hetaryl substituted homotetramic and homtetronic acids and the use thereof as pesticides |
| 05/20/2004 | US20040097546 For therapy of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction |
| 05/20/2004 | US20040097533 Useful as potassium channel blockers and antiarrhythmic drugs |
| 05/20/2004 | US20040097524 For therapy and prophylaxis of disorder in which the blocking of purine receptors, particularly adenosine receptors and more may be beneficial, such a Parkinson's disease or depression, cognitive or memory impairment, pain |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097497 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097485 For therapy and prophylaxis of disease or condition associated with inflammation, a metabolic disorder, infection, cancer or an immune disease or condition |
| 05/20/2004 | US20040096787 Color photography |
| 05/20/2004 | US20040096397 Sulfonated diarylrhodamine dyes |
| 05/20/2004 | US20040094753 Photochromic compound exhibits absorption bands in two wavelength regions of 440 to 500 nm and 570 to 630 nm. |
| 05/19/2004 | EP1420023A1 Fused pyrazolyl compounds |
| 05/19/2004 | EP1419163A1 Tricyclic imidazopyridines |
| 05/19/2004 | EP1419156A1 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
| 05/19/2004 | EP1419155A2 Piperidine derivatives as antibacterial agents |
| 05/19/2004 | EP1200089B1 Pyridomorphinans and use thereof |
| 05/19/2004 | EP1110951B1 Pyrimidine derivatives |
| 05/19/2004 | EP1025102B1 Bicyclic kinase inhibitors |
| 05/19/2004 | EP1021418B1 Substituted 2,3-benzodiazepin-4-ones and the use thereof |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/19/2004 | EP0947513B1 Tricyclic amine derivatives |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | CN1498219A Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b] quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl) acetamide |
| 05/19/2004 | CN1498106A Pharmaceutical forms of epothilones for oral administration |
| 05/19/2004 | CN1496989A New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them |
| 05/19/2004 | CN1150198C Process for producing hexahydrothiopheno-[3,4-d]imidzaole-2,4-diketones compound |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150166C CB2 receptor agonist compounds |
| 05/18/2004 | US6737424 Alpha-substituted pyridazino quinoline compounds |
| 05/18/2004 | US6737280 Used as labeling groups in procedures for the detection of analytes; asymmetric monobenzoxanthene compounds |
| 05/18/2004 | US6737142 Optical data store comprising an axially substituted cobalt phthalocyanine in the light-writeable information layer |
| 05/18/2004 | CA2265881C Nodulisporic acid derivatives |
| 05/13/2004 | WO2004039894A2 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 05/13/2004 | WO2004039317A2 Analogs and prodrugs of buprenorphine |
| 05/13/2004 | WO2004014917A3 Antitumoral analogs of lamellarins |
| 05/13/2004 | US20040092743 Indeno(2,1-f) chromene derivatives for ophthalmic lenses |
| 05/13/2004 | US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 05/13/2004 | US20040092740 Hyperpermeability; diabetic retinopathy, ischemic retinal-vein occlusion, prematurity, age-related macular degeneration |
| 05/13/2004 | US20040092582 Antiinflammatory agents; respiratory system disorders; antiarthritic agents; autoimmune diseases; antidiabetic agents |
| 05/13/2004 | US20040092573 Anticholesterol agents |
| 05/13/2004 | CA2484218A1 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 05/12/2004 | EP1417208A1 Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases |
| 05/12/2004 | EP1417202A2 Aminopiperidine derivatives as modulators of chemokine receptor activity |
| 05/12/2004 | EP1018514B1 NF-$g(k)B INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT |
| 05/12/2004 | CN1496352A Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and use of same as analgesics |
| 05/12/2004 | CN1496256A Combination of EPOTHILONE analogs and chemotherapeutic agents for treatment of proliferative diseases |
| 05/12/2004 | CN1495186A Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 05/12/2004 | CN1495183A Para-herqueinamide as medicine for resisting parasite |
| 05/12/2004 | CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 05/12/2004 | CN1495165A Indane or indoline derivative |
| 05/12/2004 | CN1149209C Triazole compounds with dopamine-D3-receptor affinity |
| 05/11/2004 | US6734312 Process for preparing a compound containing a heteroaromatic group with one or more ether substituents |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734191 Chemokine receptor binding heterocyclic compounds |
| 05/11/2004 | US6734189 Hydroxamic and carboxylic acid derivatives |
| 05/11/2004 | US6734180 NF-κB inhibitor comprising an indan derivative as an active ingredient |
| 05/06/2004 | WO2004037831A1 Novel substituted[1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | WO2004037788A1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases |
| 05/06/2004 | WO2004037373A2 CHEMICAL CHAPERONES AND THEIR EFFECT UPON THE CELLULAR ACTIVITY OF β-GLUCOSIDASE |
| 05/06/2004 | WO2004037170A2 Process for making spirolactone compounds |
| 05/06/2004 | WO2004037169A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/06/2004 | WO2004022537A3 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands |
| 05/06/2004 | WO2003092580A3 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 05/06/2004 | WO2003004467A3 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 05/06/2004 | WO2001072754A9 Alkylated imidazopyridine derivatives |
| 05/06/2004 | US20040087806 Processes for preparing 1,3-dioxolane nucleosides |
| 05/06/2004 | US20040087800 Spirooxindole derivatives are analgesics for the treatment of chronic pain. |
| 05/06/2004 | US20040087639 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia |
| 05/06/2004 | US20040087620 Terphenyl compounds bearing substituted amino groups |
| 05/06/2004 | US20040087609 Process for producing camptothecin |
| 05/06/2004 | US20040087600 Amino-substituted dihydropyrimido[4,5-D]pyrimidinone derivatives |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/06/2004 | US20040086746 Organic light emitting diode and organic luminescent materials thereof |
| 05/06/2004 | EP1416017A1 Fluorescent nucleosides, nucleotides or polynucleotides containing a rhodamine dye |
| 05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
| 05/06/2004 | EP1415986A1 Spiro compounds |
| 05/06/2004 | EP1415651A1 Preventives/remedies for cholinergic neuropathy |
| 05/06/2004 | EP1414821A1 Tricyclic epoxides |
| 05/06/2004 | EP1414813A1 1,2,4-trioxolane antimalarials |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414792A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 05/06/2004 | EP1414458A1 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1036072B1 Thrombin receptor antagonists |
| 05/06/2004 | CA2502488A1 Novel substituted[1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | CA2502282A1 Process for making spirolactone compounds |
| 05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 05/05/2004 | CN1493572A New method for extracting cephalotaxine and percephalotaxine |
| 05/05/2004 | CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase |
| 05/05/2004 | CN1148187C Application of tetrandrine its agonist for preparing medicine for treatment of ocular inflammation |